Reduced High-Affinity Agonist Binding at the M 1 Muscarinic Receptor in Alzheimer's Disease Brain: Differential Sensitivity to Agonists and Divalent Cations

Author： Ladner C.J.   Lee J.M.  

Publisher： Elsevier

ISSN： 0014-4886

Source： Experimental Neurology, Vol.158, Iss.2, 1999-08, pp. : 451-458

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

M1 Muscarinic Agonists Target Major Hallmarks of Alzheimer's Disease -an Update

By  

Current Alzheimer Research, Vol. 4, Iss. 5, 2007-12 ,pp. : 577-580

Bentham Science Publishers

Access to resources Recommend Favorite

Towards a High-Affinity Allosteric Enhancer at Muscarinic M1 Receptors

By Lazareno S.   Popham A.   Birdsall N.J.M.  

Journal of Molecular Neuroscience, Vol. 19, Iss. 1-2, 2002-10 ,pp. : 123-128

Humana Press, Inc

Access to resources Recommend Favorite

Progress toward a high-affinity allosteric enhancer at muscarinic M1 receptors

By Lazareno Sebastian   Popham Angela   Birdsall Nigel  

Journal of Molecular Neuroscience, Vol. 20, Iss. 3, 2003-08 ,pp. : 363-367

Humana Press, Inc

Access to resources Recommend Favorite

M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer’s disease: Implications in future therapy

By Fisher Abraham   Pittel Zipora   Haring Rachel   Bar-Ner Nira   Kliger-Spatz Michal   Natan Niva   Egozi Inbal   Sonego Hagar   Marcovitch Itzhak   Brandeis Rachel  

Journal of Molecular Neuroscience, Vol. 20, Iss. 3, 2003-08 ,pp. : 349-356

Humana Press, Inc

Access to resources Recommend Favorite

Chronic Administration of a Partial Muscarinic M 1 Receptor Agonist Attenuates Decreases in Forebrain Choline Acetyltransferase Immunoreactivity Following Experimental Brain Trauma

By Pike B.R.   Hamm R.J.  

Experimental Neurology, Vol. 147, Iss. 1, 1997-09 ,pp. : 55-65

Elsevier

Access to resources Recommend Favorite